Skip to main content

Table 2 Characteristics of patients and their MGMT promoter methylation status determined by HRM, MSP, and PSQ in 65 IDH1 wt malignant gliomas

From: MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response

Characteristics n HRM me (%) MSP me (%) PSQ me (%)
All patients 65 41.5 30.8 46.2
Woman 22 40.9 31.8 40.9
Man 43 41.9 30.2 48.8
Age ≥70 27 44.4 25.9 44.4
Age <70 38 39.5 34.2 47.4
Grade III 7 42.9 42.9 42.9
Grade IV 58 41.4 29.3 46.6
\